Please login to the form below

Using TRAVELLESS™ to provide tailored pharmaceutical training

In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry.

With the current global situation relating to COVID-19, restrictions on travel and face-to-face group meetings are in place. As a result, it looked set to prevent our contribution to the course from happening. However, cue TRAVELLESS™, our proprietary virtual solution…

By using TRAVELLESS™, we were able to deliver our sessions online to nearly 60 participants, with attendees joining each morning from the comfort of their own homes. The participants were not just present from France, with many students signing into the course from all over the world. The teaching used several interactive techniques, such as live polls and chat, whilst learning exercises were conducted using breakout rooms, allowing participants to work in small, private teams, then present their work back to the group. While we regularly use such formats when delivering our client training, the interactive nature of this teaching was considered to be novel and appreciated by the students:

“The platform is amazing, and you held good interaction with us. You nailed the virtual meeting perfectly.”

Throughout the week, the input and interaction from the students was excellent, with the students highlighting why the course is held in such high esteem. Through the TRAVELLESS™ platform, course attendees were given the chance to engage with the material delivered by our trainers and they took full advantage of this by really getting involved in the nature of the teachings.

“It was perfectly done guys, the fact that you involved us in the sessions with question and exercises is really important to stay focussed.”

“Clearly experienced teachers who explained well several concepts of market access.”

A successful and enjoyable week was had by all, and we were delighted that our TRAVELLESS™ solution could allow the sessions to be delivered. At Valid Insight, we would like to thank Mark Chanel for inviting us to deliver the sessions. We would also like to thank the students for joining us; we are thrilled that you enjoyed taking part.

To learn more about the training services we offer, or to find out how our experienced consultants and TRAVELLESS™ platform could provide a tailored solution to your needs for training pharmaceutical teams, for strategic workshops or payer advisory boards, please contact us at discover@validinsight.com.

This article was first published here: https://www.validinsight.com/events-news/using-travelless-to-provide-tailored-pharmaceutical-training/

20th May 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Valid Insight are hiring for Consultants in Value Communication (mid to senior levels)
New role available for Consultants in Value Communication with experience in market access writing and value communication.
Valid Insight
Webinar: Maintaining market access through a pandemic, 6 months on
In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.
Valid Insight
Webinar: How to develop an optimal value story for your product
This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight